GREGORY SARGEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY SARGEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY SARGEN. GREGORY SARGEN is CFO & EVP, Corp. Dev. in CAMBREX CORP ($CBM) and EVP & CFO in CAMBREX CORP ($CBM) and EVP, Corporate Development in CAMBREX CORP ($CBM) and Executive Vice President & CFO in CAMBREX CORP ($CBM) and Vice President in CAMBREX CORP ($CBM) and Vice President & CFO in CAMBREX CORP ($CBM) and Vice President, Finance in CAMBREX CORP ($CBM) and Vice President-Finance in CAMBREX CORP ($CBM) and Director in PEREGRINE PHARMACEUTICALS INC ($PPHM) and Director in ArTara Therapeutics, Inc. ($PRTO).
Latest Insider Trading Transactions of GREGORY SARGEN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PPHM, CBM, TARA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | TARA | Protara Therapeuti ... | SARGEN GREGORY | Director | Option Exercise | A | 10.51 | 10,000 | 105,100 | 10,000 | |
| Dec 16 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 0.00 | 2,379 | 0 | 2,379 | |
| Dec 16 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 10.72 | 10,030 | 107,522 | 124,305 | |
| Jun 11 2020 | TARA | Protara Therapeuti ... | SARGEN GREGORY | Director | Option Exercise | A | 35.00 | 9,000 | 315,000 | 9,000 | |
| Jan 13 2020 | PRTO | ArTara Therapeutic ... | SARGEN GREGORY | Director | Grant | A | 0.00 | 31,000 | 0 | 31,000 | 0 to 31 K |
| Jan 13 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
| Jan 13 2020 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 6.87 | 19,675 | 135,167 | 114,275 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 53.61 | 20,000 | 1,072,100 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 45.64 | 25,000 | 1,140,875 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 40.65 | 22,500 | 914,625 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 41.36 | 15,000 | 620,400 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 17.81 | 7,500 | 133,575 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Sell | S | 60.00 | 165,925 | 9,955,500 | 0 | 165.9 K to 0 (-100.00 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Grant | A | 0.00 | 43,500 | 0 | 165,925 | 122.4 K to 165.9 K (+35.53 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 53.61 | 20,000 | 1,072,100 | 122,425 | 102.4 K to 122.4 K (+19.53 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 45.64 | 25,000 | 1,140,875 | 102,425 | 77.4 K to 102.4 K (+32.29 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 40.65 | 22,500 | 914,625 | 77,425 | 54.9 K to 77.4 K (+40.96 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 41.36 | 15,000 | 620,400 | 54,925 | 39.9 K to 54.9 K (+37.57 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 17.81 | 7,500 | 133,575 | 39,925 | 32.4 K to 39.9 K (+23.13 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 53.61 | 20,000 | 1,072,100 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 45.64 | 25,000 | 1,140,875 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 40.65 | 22,500 | 914,625 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 41.36 | 15,000 | 620,400 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Option Exercise | M | 17.81 | 7,500 | 133,575 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Sell | S | 60.00 | 165,925 | 9,955,500 | 0 | 165.9 K to 0 (-100.00 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Grant | A | 0.00 | 43,500 | 0 | 165,925 | 122.4 K to 165.9 K (+35.53 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 53.61 | 20,000 | 1,072,100 | 122,425 | 102.4 K to 122.4 K (+19.53 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 45.64 | 25,000 | 1,140,875 | 102,425 | 77.4 K to 102.4 K (+32.29 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 40.65 | 22,500 | 914,625 | 77,425 | 54.9 K to 77.4 K (+40.96 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 41.36 | 15,000 | 620,400 | 54,925 | 39.9 K to 54.9 K (+37.57 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Buy | M | 17.81 | 7,500 | 133,575 | 39,925 | 32.4 K to 39.9 K (+23.13 %) |
| Feb 19 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Sell | S | 37.45 | 5,802 | 217,285 | 32,425 | 38.2 K to 32.4 K (-15.18 %) |
| Feb 19 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | CFO & EVP, Corp. De ... | Grant | A | 0.00 | 12,000 | 0 | 38,227 | 26.2 K to 38.2 K (+45.75 %) |
| Feb 04 2019 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 0.00 | 6,227 | 0 | 26,227 | 20 K to 26.2 K (+31.14 %) |
| Dec 18 2018 | PPHM | Avid Bioservices, ... | SARGEN GREGORY | Director | Option Exercise | A | 5.22 | 19,600 | 102,312 | 94,600 | |
| Oct 26 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | A | 53.61 | 20,000 | 1,072,100 | 20,000 | |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | M | 40.65 | 7,500 | 304,875 | 22,500 | |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | M | 41.36 | 15,000 | 620,400 | 15,000 | |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | M | 17.81 | 7,500 | 133,575 | 7,500 | |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | M | 16.91 | 7,500 | 126,788 | 0 | |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Sell | S | 49.63 | 33,933 | 1,683,939 | 20,000 | 53.9 K to 20 K (-62.92 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Sell | S | 49.05 | 10,565 | 518,213 | 53,933 | 64.5 K to 53.9 K (-16.38 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 40.65 | 7,500 | 304,875 | 64,498 | 57 K to 64.5 K (+13.16 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 41.36 | 15,000 | 620,400 | 56,998 | 42 K to 57 K (+35.72 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 17.81 | 7,500 | 133,575 | 41,998 | 34.5 K to 42 K (+21.74 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 16.91 | 7,500 | 126,788 | 34,498 | 27 K to 34.5 K (+27.78 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Sell | S | 49.46 | 23,002 | 1,137,720 | 26,998 | 50 K to 27 K (-46.00 %) |
| May 09 2018 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 0.00 | 30,000 | 0 | 50,000 | 20 K to 50 K (+150.00 %) |
| Nov 29 2017 | PPHM | PEREGRINE PHARMACE ... | SARGEN GREGORY | Director | Option Exercise | A | 4.67 | 75,000 | 350,250 | 75,000 | |
| Nov 01 2017 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Option Exercise | A | 45.64 | 25,000 | 1,140,875 | 25,000 | |
| Feb 08 2017 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Sell | S | 54.88 | 30,000 | 1,646,400 | 20,000 | 50 K to 20 K (-60.00 %) |
| Feb 08 2017 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP, Corporate Deve ... | Grant | A | 0.00 | 30,000 | 0 | 50,000 | 20 K to 50 K (+150.00 %) |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 17.81 | 7,500 | 133,575 | 15,000 | |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 16.91 | 7,500 | 126,825 | 7,500 | |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 12.46 | 7,500 | 93,450 | 0 | |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 52.02 | 22,500 | 1,170,450 | 20,000 | 42.5 K to 20 K (-52.94 %) |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 17.81 | 7,500 | 133,575 | 42,500 | 35 K to 42.5 K (+21.43 %) |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 16.91 | 7,500 | 126,825 | 35,000 | 27.5 K to 35 K (+27.27 %) |
| Nov 14 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 12.46 | 7,500 | 93,450 | 27,500 | 20 K to 27.5 K (+37.50 %) |
| Oct 28 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | A | 40.65 | 30,000 | 1,219,500 | 30,000 | |
| Mar 11 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | S | 41.37 | 26,697 | 1,104,455 | 20,000 | -6,697 to 20 K (-398.64 %) |
| Feb 12 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 36.63 | 1,222 | 44,762 | 46,697 | 47.9 K to 46.7 K (-2.55 %) |
| Feb 12 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 36.11 | 12,400 | 447,764 | 47,919 | 60.3 K to 47.9 K (-20.56 %) |
| Feb 12 2016 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Grant | A | 0.00 | 27,000 | 0 | 60,319 | 33.3 K to 60.3 K (+81.03 %) |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 17.81 | 7,500 | 133,575 | 22,500 | |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 16.91 | 7,500 | 126,788 | 15,000 | |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 12.46 | 7,500 | 93,450 | 7,500 | |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 5.72 | 6,250 | 35,750 | 0 | |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 49.14 | 28,750 | 1,412,775 | 33,319 | 62.1 K to 33.3 K (-46.32 %) |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 17.81 | 7,500 | 133,575 | 62,069 | 54.6 K to 62.1 K (+13.74 %) |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 16.91 | 7,500 | 126,788 | 54,569 | 47.1 K to 54.6 K (+15.93 %) |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 12.46 | 7,500 | 93,450 | 47,069 | 39.6 K to 47.1 K (+18.95 %) |
| Nov 16 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 5.72 | 6,250 | 35,750 | 39,569 | 33.3 K to 39.6 K (+18.76 %) |
| Oct 27 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | A | 41.36 | 30,000 | 1,240,800 | 30,000 | |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 5.72 | 18,750 | 107,250 | 6,250 | |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 16.91 | 7,500 | 126,788 | 22,500 | |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 12.46 | 15,000 | 186,900 | 15,000 | |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 49.60 | 41,250 | 2,046,000 | 33,319 | 74.6 K to 33.3 K (-55.32 %) |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 5.72 | 18,750 | 107,250 | 74,569 | 55.8 K to 74.6 K (+33.59 %) |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 16.91 | 7,500 | 126,788 | 55,819 | 48.3 K to 55.8 K (+15.52 %) |
| Aug 05 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 12.46 | 15,000 | 186,900 | 48,319 | 33.3 K to 48.3 K (+45.02 %) |
| May 12 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 4.38 | 25,000 | 109,500 | 0 | |
| May 12 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 38.44 | 25,000 | 961,013 | 33,319 | 58.3 K to 33.3 K (-42.87 %) |
| May 12 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 4.38 | 25,000 | 109,500 | 58,319 | 33.3 K to 58.3 K (+75.03 %) |
| Feb 13 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 4.38 | 25,000 | 109,500 | 25,000 | |
| Feb 13 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 32.64 | 25,000 | 815,983 | 33,319 | 58.3 K to 33.3 K (-42.87 %) |
| Feb 13 2015 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 4.38 | 25,000 | 109,500 | 58,319 | 33.3 K to 58.3 K (+75.03 %) |
| Oct 23 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 17.81 | 30,000 | 534,300 | 30,000 | |
| Aug 07 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 5.51 | 50,000 | 275,500 | 0 | |
| Aug 07 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 22.34 | 50,000 | 1,116,980 | 33,319 | 83.3 K to 33.3 K (-60.01 %) |
| Aug 07 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 5.51 | 50,000 | 275,500 | 83,319 | 33.3 K to 83.3 K (+150.06 %) |
| Feb 20 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 5.51 | 30,000 | 165,300 | 50,000 | |
| Feb 20 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 13.75 | 8,500 | 116,875 | 0 | |
| Feb 20 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 21.66 | 38,500 | 833,987 | 33,319 | 71.8 K to 33.3 K (-53.61 %) |
| Feb 20 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 5.51 | 30,000 | 165,300 | 71,819 | 41.8 K to 71.8 K (+71.74 %) |
| Feb 20 2014 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 13.75 | 8,500 | 116,875 | 41,819 | 33.3 K to 41.8 K (+25.51 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Option Exercise | M | 5.51 | 20,000 | 110,200 | 80,000 | |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 18.90 | 15,822 | 299,036 | 33,319 | 49.1 K to 33.3 K (-32.20 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 18.96 | 1,063 | 20,154 | 49,141 | 50.2 K to 49.1 K (-2.12 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 18.97 | 1,200 | 22,764 | 50,204 | 51.4 K to 50.2 K (-2.33 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 18.98 | 200 | 3,796 | 51,404 | 51.6 K to 51.4 K (-0.39 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 18.99 | 411 | 7,805 | 51,604 | 52 K to 51.6 K (-0.79 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 19.01 | 604 | 11,482 | 52,015 | 52.6 K to 52 K (-1.15 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 19.02 | 100 | 1,902 | 52,619 | 52.7 K to 52.6 K (-0.19 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 19.03 | 100 | 1,903 | 52,719 | 52.8 K to 52.7 K (-0.19 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 19.05 | 400 | 7,620 | 52,819 | 53.2 K to 52.8 K (-0.75 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Sell | S | 19.07 | 100 | 1,907 | 53,219 | 53.3 K to 53.2 K (-0.19 %) |
| Nov 12 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | EVP & CFO | Buy | M | 5.51 | 20,000 | 110,200 | 53,319 | 33.3 K to 53.3 K (+60.03 %) |
| Oct 30 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | A | 16.91 | 30,000 | 507,150 | 30,000 | |
| May 08 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | M | 7.39 | 2,500 | 18,475 | 0 | |
| May 08 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Sell | S | 12.42 | 2,500 | 31,050 | 33,319 | 35.8 K to 33.3 K (-6.98 %) |
| May 08 2013 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Buy | M | 7.39 | 2,500 | 18,475 | 35,819 | 33.3 K to 35.8 K (+7.50 %) |
| Oct 26 2012 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | A | 12.46 | 30,000 | 373,800 | 30,000 | |
| Oct 20 2011 | CBM | CAMBREX CORP | SARGEN GREGORY | Executive Vice Pres ... | Option Exercise | A | 5.72 | 25,000 | 143,000 | 25,000 | |
| Apr 23 2010 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Option Exercise | M | 4.38 | 50,000 | 219,000 | 50,000 | |
| Feb 16 2010 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Grant | A | 0.00 | 22,684 | 0 | 32,396 | 9.7 K to 32.4 K (+233.57 %) |
| May 20 2009 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Sell | I | 0.00 | 1,256 | 0 | 0 | 1.3 K to 0 (-100.00 %) |
| Apr 25 2008 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Option Exercise | M | 5.51 | 100,000 | 551,000 | 100,000 | |
| Jan 28 2008 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Grant | A | 0.00 | 15,634 | 0 | 21,134 | 5.5 K to 21.1 K (+284.25 %) |
| Jan 28 2008 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Buy | J | 0.00 | 63 | 0 | 1,256 | 1.2 K to 1.3 K (+5.28 %) |
| Jul 30 2007 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Option Exercise | M | 13.75 | 8,500 | 116,875 | 8,500 | |
| Jul 30 2007 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President & CF ... | Grant | A | 0.00 | 4,500 | 0 | 5,500 | 1,000 to 5.5 K (+450.00 %) |
| May 07 2007 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President | Option Exercise | A | 7.39 | 2,500 | 18,475 | 2,500 | |
| May 07 2007 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President | Option Exercise | D | 21.39 | 2,500 | 53,475 | 0 | |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Option Exercise | M | 21.90 | 5,000 | 109,513 | 0 | |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Option Exercise | M | 21.90 | 5,000 | 109,513 | 5,000 | |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Option Exercise | M | 20.72 | 7,000 | 145,040 | 0 | |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Option Exercise | M | 18.68 | 75,000 | 1,400,625 | 0 | |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.92 | 400 | 9,168 | 26,600 | 27 K to 26.6 K (-1.48 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.80 | 400 | 9,120 | 27,000 | 27.4 K to 27 K (-1.46 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.79 | 200 | 4,558 | 27,400 | 27.6 K to 27.4 K (-0.72 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.78 | 300 | 6,834 | 27,200 | 27.5 K to 27.2 K (-1.09 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.77 | 800 | 18,216 | 27,500 | 28.3 K to 27.5 K (-2.83 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.76 | 800 | 18,208 | 28,300 | 29.1 K to 28.3 K (-2.75 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.74 | 500 | 11,370 | 29,100 | 29.6 K to 29.1 K (-1.69 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.73 | 1,000 | 22,730 | 29,600 | 30.6 K to 29.6 K (-3.27 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.72 | 3,300 | 74,976 | 30,600 | 33.9 K to 30.6 K (-9.73 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.71 | 400 | 9,084 | 33,900 | 34.3 K to 33.9 K (-1.17 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.70 | 1,100 | 24,970 | 34,300 | 35.4 K to 34.3 K (-3.11 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.69 | 7,100 | 161,099 | 35,400 | 42.5 K to 35.4 K (-16.71 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.68 | 3,900 | 88,452 | 42,500 | 46.4 K to 42.5 K (-8.41 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.67 | 3,100 | 70,277 | 46,400 | 49.5 K to 46.4 K (-6.26 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.66 | 1,700 | 38,522 | 49,500 | 51.2 K to 49.5 K (-3.32 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.65 | 2,000 | 45,300 | 51,200 | 53.2 K to 51.2 K (-3.76 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.64 | 1,600 | 36,224 | 53,200 | 54.8 K to 53.2 K (-2.92 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.63 | 700 | 15,841 | 54,800 | 55.5 K to 54.8 K (-1.26 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.62 | 15,500 | 350,610 | 55,500 | 71 K to 55.5 K (-21.83 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.61 | 600 | 13,566 | 71,000 | 71.6 K to 71 K (-0.84 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.60 | 8,600 | 194,360 | 71,600 | 80.2 K to 71.6 K (-10.72 %) |
| Nov 16 2006 | CBM | CAMBREX CORP | SARGEN GREGORY | Vice President-Fina ... | Sell | S | 22.59 | 2,100 | 47,439 | 80,200 | 82.3 K to 80.2 K (-2.55 %) |